But even for Crestor, the absolute risk of a serious problem was very low - 1 in 35,862. When side effects did occur, it tended to be within the first three months' of use.

WASHINGTON AstraZeneca's recent full-page newspaper advertisements defending the safety of its cholesterol-lowering pill, Crestor, are "false and misleading," in part because serious concerns remain ...